- Molecules
- 9
MedsAcross lists 9 molecules linked to Neuroblastoma, susceptibility to, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- DoxorubicinOrphanAnthracycline Topoisomerase Inhibitor15 presentations5 brandsL01DB01
- CarboplatinPlatinum-based Drug6 presentations1 brandL01XA02
- IrinotecanOrphanTopoisomerase Inhibitor8 presentations3 brandsL01CE02
- CisplatinPlatinum-based Drug5 presentations1 brandL01XA01
- EtoposideTopoisomerase Inhibitor8 presentations3 brandsL01CB01
- TopotecanTopoisomerase Inhibitor5 presentations5 brandsL01CE01
- CrizotinibOrphanKinase Inhibitor5 presentations2 brandsL01ED01
- MelphalanOrphanAlkylating Drug2 presentations2 brandsL01AA03
- DinutuximabOrphanGlycolipid Disialoganglioside-directed Antibody1 presentation1 brandL01FX06
Access for rare diseases
Medicines for rare diseases are often not registered in the patient's country. Named-patient and special access routes let a physician or hospital import them legally.
Orphan and rare disease medicinesFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Neuroblastoma, susceptibility to?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.